Evidence map›Paper›PMID 40492016›Full record

ArticleJCEM case reports2025

Alpelisib Therapy in 2 Patients With Congenital Hyperinsulinism.

Khalid Alburshad, Rasha Amin, Hajar Dauleh, Marwa Ibrahim, Khalid Hussain

Abstract readCase Reports
In one paragraph

Article in JCEM case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Khalid AlburshadEndocrinology Department, Sidra Medicine, PO BOX 26999, Doha, Qatar.
Rasha AminEndocrinology Department, Sidra Medicine, PO BOX 26999, Doha, Qatar.
Hajar DaulehEndocrinology Department, Sidra Medicine, PO BOX 26999, Doha, Qatar.
Marwa IbrahimEndocrinology Department, Sidra Medicine, PO BOX 26999, Doha, Qatar.
Khalid HussainEndocrinology Department, Sidra Medicine, PO BOX 26999, Doha, Qatar.ORCID https://orcid.org/0000-0002-5480-7112

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Congenital hyperinsulinism (CHI) is a disorder of unregulated insulin secretion, leading to severe hypoglycemia in most cases. We previously described the adjunct use of alpelisib therapy in a 3-month-old patient with CHI. We now describe our observations in 2 additional patients with severe CHI treated with alpelisib therapy, resulting in discontinuation of all existing treatments and normalization of feeding. Two children (aged 3 and 4 years) with CHI (homozygous

Indexed as

alpelisibcongenital hyperinsulinismhypoglycemiaKCNJ11 pathological variantUsher syndrome

Identifiers

PMID40492016
PMCPMC12146258

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.